Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The combination of cagrilintide with retatrutide is not available in the UK and does not exist as a licensed or registered investigational product
Every batch is independently analysed by Janoshik Analytical, with purity, heavy metals and endotoxin results published in our COA library
Our team is committed to ensuring that your order arrives after research is needed to fully understand its mechanisms of action and potential applications in the treatment of various conditions
Scientific content reviewed by an MBBS-qualified medical reviewer
In 2023, the agency reclassified BPC-157 and 18 other manmade peptides as Category 2 Bulk Drug Substances, effectively barring compounding pharmacies from producing them, citing safety concerns and insufficient information on their effects in humans
